This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Inventor Kai Zhao
Introduction
Kai Zhao is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on inclusion complexes. His research focuses on enhancing the solubility and therapeutic effects of butylphthalide, a compound with potential clinical applications.
Latest Patents
Kai Zhao holds a patent for "Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof." This invention relates to the complexation of butylphthalide with cyclodextrin or its derivatives, specifically hydroxypropyl-β-cyclodextrin. The aim is to increase the water solubility of butylphthalide, facilitating the development of various clinical formulations such as infusions, injections, and oral liquids. The patent highlights a molar ratio of butylphthalide to cyclodextrin ranging from 1:1 to 10, which is crucial for preparing effective pharmaceutical products.
Career Highlights
Throughout his career, Kai Zhao has worked with prominent companies in the pharmaceutical industry. He has been associated with Shijiazhuang Pharmaceutical Group and Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and delivery systems.
Collaborations
Kai Zhao has collaborated with several professionals in his field, including Zhan-qi Niu and Wen-juan Liu. These collaborations have fostered a productive environment for research and innovation, leading to significant developments in pharmaceutical applications.
Conclusion
In summary, Kai Zhao is an influential inventor whose work on butylphthalide inclusion complexes has the potential to enhance therapeutic outcomes in clinical settings. His contributions to the pharmaceutical industry reflect a commitment to innovation and improvement in drug formulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile